ReviewEuropean archives of psychiatry and clinical neuroscience2013
Depressive syndromes in neurological disorders.
Review in European archives of psychiatry and clinical neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.
- Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.Progress in neuro-psychopharmacology & biological psychiatry · 2015Pooled it
- Panax quinquefolius ginsenosides for neuroprotection in Parkinson's disease via TNF-α inhibition.Journal of natural medicines · 2026Article
- Late-Onset Depression in an Aging World: A Multidimensional Perspective on Risks, Mechanisms, and Treatment.Geriatrics (Basel, Switzerland) · 2026Review
- The effect of motivational interviewing on patients with early post-stroke depression: a quasi-experimental study.BMC psychiatry · 2025Article
- Ipsa senectus morbus est? Approaching the unmet needs in geriatric depression: results from a national survey of medical experts.Frontiers in psychiatry · 2025Article
- Neurologic comorbidity in psychiatric inpatients: evidence from neurologic consultations in a Spanish center.Revista de neurologia · 2024Article
- Multivariate base rates of potentially problematic scores on the NIH Toolbox Emotion Battery.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2024Article
- Case report: Personalizing the use of trazodone in real-world patients: a study of three cases of depression with comorbidities.Frontiers in psychiatry · 2024Article
- Critical Roles of Protein Arginine Methylation in the Central Nervous System.Molecular neurobiology · 2023Review
- Article
- Validation of a comorbidity questionnaire in patients with neurological disorders.BMJ neurology open · 2023Article
- Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone.Frontiers in psychiatry · 2023Review
- Glutamate Efflux across the Blood-Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System.Metabolites · 2022Review
- Prediction of Poststroke Depression Based on the Outcomes of Machine Learning Algorithms.Journal of clinical medicine · 2022Article
- Age- and frequency-dependent changes in dynamic contrast perception in visual snow syndrome.The journal of headache and pain · 2021Article
- Article
- Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.Acta neurologica Scandinavica · 2020Article
- Fatigue in Multiple Sclerosis Is Associated With Childhood Adversities.Frontiers in psychiatry · 2020Article
- Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence.Frontiers in psychiatry · 2018Review
- Charting the perfect storm: emerging biological interfaces between stress and stroke.European archives of psychiatry and clinical neuroscience · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depressive syndromes represent a common and often characteristic feature in a number of neurological disorders. One prominent example is the development of post-stroke depression, which can be observed in more than one-third of stroke survivors in the aftermath of an ischemic stroke. Thus, post-stroke depression represents one of the most prevalent, disabling, and potentially devastating psychiatric post-stroke complications. On the other hand, depressive syndromes may also be considered as a risk factor for certain neurological disorders, as recently revealed by a meta-analysis of prospective cohort studies, which demonstrated an increased risk for ischemic events in depressed patients. Moreover, depressive syndromes represent common comorbidities in a number of other neurological disorders such as Parkinson's disease, multiple sclerosis, or epilepsy, in which depression has a strong impact on both quality of life and outcome of the primary neurological disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.